Vol 72, No 1 (2021)
Clinical vignette
Published online: 2020-12-08

open access

Page views 1092
Article views/downloads 613
Get Citation

Connect on Social Media

Connect on Social Media

A combination of plasma exchange and steroids in the treatment of a-lipoic acid-induced insulin autoimmune syndrome

Xiao Sheng1, Xinhua Ye1, Xiaoqi Shi1, Lin Lu1, Aijiao Lu1, Yun Xue1, Yunfeng Du1, Jinluo Cheng1
Pubmed: 33295634
Endokrynol Pol 2021;72(1):81-82.


Not required for Clinical Vignette.

Article available in PDF format

View PDF Download PDF file


  1. Uchigata Y, Hirata Y. Insulin autoimmune syndrome (IAS, Hirata disease). Ann Med Interne (Paris). 1999; 150(3): 245–253.
  2. Takeuchi Y, Miyamoto T, Kakizawa T, et al. Insulin Autoimmune Syndrome possibly caused by alpha lipoic acid. Intern Med. 2007; 46(5): 237–239.
  3. Uchigata Y, Hirata Y, Omori Y, et al. Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA-DR4 alleles. Hum Immunol. 2000; 61(2): 154–157.
  4. Chu JP, Zheng XW, Lu J, et al. Insulin-induced autoimmune syndrome: A case report. Exp Ther Med. 2016; 12(5): 3359–3362.
  5. Saxon DR, McDermott MT, Michels AW. Novel Management of Insulin Autoimmune Syndrome with Rituximab and Continuous Glucose Monitoring. J Clin Endocrinol Metab. 2016; 101(5): 1931–1934.